Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model - Wikidata - awgldk - TriplyDB

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

http://www.wikidata.org/entity/Q24804031

about

Mesenchymal Stem Cells Yield Transient Improvements in Motor Function in an Infant Rhesus Macaque with Severe Early-Onset Krabbe Disease.Experimental therapies in the murine model of globoid cell leukodystrophy.Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes.Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy Effect of intrastriatal mesenchymal stromal cell injection on progression of a murine model of Krabbe disease.Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease.Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse.MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy.Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease.Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatment.Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.Treatment for Krabbe's disease: Finding the combination.Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis.Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death.The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain.Using Case Studies to Promote Student Engagement in Primary Literature Data Analysis and Evaluation.

P2860

Q33722223-5A2E892B-7222-48B1-9BDB-252CBF246C78 Q34439689-C1C5772C-695F-432A-A5B5-9CFC741C731C Q34642112-F5361874-3703-4ACC-877F-5026B9F7E905 Q34912498-743766E8-7B89-4F02-88B9-48894C7D0B08 Q35231459-496CE935-E0DB-4938-B365-1724AAD34F17 Q35515608-587414BC-6975-455A-93F9-A3D789F292CF Q36141625-0F56534F-2C70-4894-B428-87C6877D211B Q36401067-D852989C-676F-4091-8413-D65099A5A7BF Q37078839-C40132BB-208C-4016-B5D2-0FAB63F471DE Q37164768-728E7240-CD83-4F87-B3F8-B8134BBD3F46 Q37244151-6996E89B-0C0D-4C8F-A4A2-FF4C6703B178 Q37447171-EA6EAEAB-A989-4882-A15B-A411E8E52A7F Q37636159-26DA3AB5-EC23-415E-AF61-FC70FE595948 Q38751654-592CCCA3-47F9-4641-8C4A-8984D991D65F Q38957246-791F3F3B-0575-4CE9-8016-77127B85E27B Q38957263-8ED06AE5-BAE5-4149-A6BA-CAD4598633FC Q39271545-4349D16C-7873-42F5-A7CF-CEA0BC5E9AAE Q40286377-7A523ABD-FC2B-4820-83BD-D48CE610B7FE Q41771736-910C7323-C62F-499F-8FD3-D8183F4C1DF3 Q49679169-FD475527-24E0-4324-814C-C6D909DDA196

P2860

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

http://www.wikidata.org/entity/Q24804031

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Anti-inflammatory therapy by i ...... a genetic demyelination model

@ast

Anti-inflammatory therapy by i ...... a genetic demyelination model

@en

Anti-inflammatory therapy by i ...... a genetic demyelination model

@nl

type

label

Anti-inflammatory therapy by i ...... a genetic demyelination model

@ast

Anti-inflammatory therapy by i ...... a genetic demyelination model

@en

Anti-inflammatory therapy by i ...... a genetic demyelination model

@nl

prefLabel

Anti-inflammatory therapy by i ...... a genetic demyelination model

@ast

Anti-inflammatory therapy by i ...... a genetic demyelination model

@en

Anti-inflammatory therapy by i ...... a genetic demyelination model

@nl

P1433

Q24804031-1B6584A4-EAAB-4499-BD42-0BE0333D25DD

P1476

Q24804031-BC49C95C-F106-4E9E-B6D1-4D3069160070

P2093

Q24804031-33B02556-BDC5-496F-84DC-D757E1139219

Q24804031-380E999A-C100-4E27-8C0E-D10A1365512E

Q24804031-74308ED9-2C18-4E3A-81BC-6A2D18C0EC51

Q24804031-B4E2CE26-42FA-41B2-A078-2F2E61AD7547

Q24804031-BB82D959-AC80-4F64-8BFA-4460C4F0A159

Q24804031-DFF54858-611F-4C99-98F9-D50A09DDF3B5

Q24804031-F746434E-00E4-4D2E-93D8-CE2224699F20

P2860

Q24804031-02EA76CD-7F47-495A-8735-C4F6DFC55718

Q24804031-032F1119-5F86-4CF8-BDF1-A007621F1CE2

Q24804031-08939306-F82A-462D-ADA6-E6CA845CCCCF

Q24804031-1342A7DA-3A26-4486-A23E-8AD60F1DB934

Q24804031-1768CB0F-2DE6-4ABC-B4EC-2652AF65BA60

Q24804031-1FEE21F1-A654-41F0-A840-C6EBFE2E91D6

Q24804031-2131F754-6E01-46B1-8F73-4FCB9011D95E

Q24804031-21FB875F-BD22-4489-B4C2-D5D56FD86C53

Q24804031-24199C7D-B0BD-4497-9667-13C803F30EEF

Q24804031-3C88DDEC-D551-4CBE-9009-B469EE3CB702

P2888

Q24804031-3C893E22-981E-48A0-B01B-FD0E188EBE79

P304

Q24804031-D2BAD747-D48A-4152-9DFF-494982E286E1

P31

Q24804031-9741F900-5435-47F6-8823-CD3BD10762C1

P356

Q24804031-AC56B207-8CA7-47B7-8484-91C66D31ED15

P433

Q24804031-9B5BDFDE-214A-42D5-918E-31C04D952029

P478

Q24804031-3A737049-7915-4915-806F-EFC45A9043BA

P577

Q24804031-8A4784D1-42D7-43F5-919C-4E5A510594A1

P5875

Q24804031-56983FEE-1BD1-4F9A-8A6B-EBD79B30E406

P6179

Q24804031-5594DC13-86D9-43CC-B649-96D371E29B44

P698

Q24804031-58571E04-B3F0-496C-B883-FA6A68C5B76B

P921

Q24804031-63C441AE-5F81-47F5-8AB7-B28C5A0738C6

P932

Q24804031-8D374738-74B7-41A6-83B5-C52A89734B48

P356

P1433

Journal of Neuroinflammation

P1476

Anti-inflammatory therapy by i ...... a genetic demyelination model

@en

P2093

Ikuko Mohri

http://www.w3.org/2001/XMLSchema#string

Keiichi Ozono

http://www.w3.org/2001/XMLSchema#string

Kinuko Suzuki

http://www.w3.org/2001/XMLSchema#string

Kuriko Kagitani-Shimono

http://www.w3.org/2001/XMLSchema#string

Masako Taniike

http://www.w3.org/2001/XMLSchema#string

Yasushi Fujitani

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Urade

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Activation of NF-kappaB by FADD, Casper, and caspase-8.

Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system.

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease.

Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.

Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice.

The twitcher mouse. A model of human globoid cell leukodystrophy (krabbe's disease)

Tumor necrosis factor identified in multiple sclerosis brain.

The twitcher mouse. Central nervous system pathology after bone marrow transplantation.

P2888

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-2-10

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7922411

http://www.w3.org/2001/XMLSchema#string

P6179

1048412881

http://www.w3.org/2001/XMLSchema#string

P698

15813970

http://www.w3.org/2001/XMLSchema#string

P921

P932

1112612

http://www.w3.org/2001/XMLSchema#string